Research programme: MegaFasL - Apoxis
Alternative Names: Mega FasLLatest Information Update: 23 Nov 2006
At a glance
- Originator Apoxis
- Class
- Mechanism of Action Apoptosis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 23 Nov 2006 No development reported - Preclinical for Cancer in Switzerland (unspecified route)
- 02 Jul 2003 Preclinical trials in Cancer in Switzerland (unspecified route)